Detalhe da pesquisa
1.
Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
; 168: 23-31, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36368129
2.
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
Gynecol Oncol
; 158(1): 167-177, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32446718
3.
Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability.
Nat Struct Mol Biol
; 30(11): 1640-1652, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37735617
4.
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma.
Front Oncol
; 13: 1286754, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38188285
5.
Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
Cancer Res
; 83(21): 3517-3528, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37494476
6.
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.
Clin Cancer Res
; 29(17): 3471-3483, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37339172
7.
Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
Clin Cancer Res
; 27(14): 4089-4100, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33963000
8.
Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis.
Sci Rep
; 11(1): 2097, 2021 01 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33483550